GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Poniard Pharmaceuticals PARD · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Poniard Pharmaceuticals

Its shares trade under the ticker PARD. It has been listed since 30 December 2011.

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of oncology products. The company is headquartered in San Francisco, California. The company went IPO on 2011-12-30. The firm focuses on the development and commercialization of oncology products to impact the lives of people with cancer. The company develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The firm has offices in San Francisco, California; and Seattle, Washington in United States.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
30 Dec 2011
Employees
20
Website
poniard.com ↗

Leadership

Pay as last reported

  • Mr. Ronald MartellChairman of the Board, since 2006$1.5m
  • Mr. Robert BassoIndependent Director
  • Dr. Frederick CravesIndependent Director, since 1993
  • Dr. Carl GoldfischerIndependent Director
  • Robert LittauerIndependent Director
  • Dr. David StevensIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Poniard Pharmaceuticals Inc has several key strengths that contribute to its competitive advantage in the market. These strengths include:

Weaknesses

  • Despite its strengths, Poniard Pharmaceuticals Inc also faces certain weaknesses that need to be addressed for sustained success:

Opportunities

  • Poniard Pharmaceuticals Inc can take advantage of several opportunities in the market to drive growth and expansion:

Threats

  • Despite the opportunities, Poniard Pharmaceuticals Inc also faces various threats which should be carefully managed:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.